These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18525228)

  • 1. A comparison of low-dose and normal-dose gadobutrol in MR renography and renal angiography.
    Bayrak IK; Ozmen Z; Nural MS; Danaci M; Diren B
    Korean J Radiol; 2008; 9(3):250-7. PubMed ID: 18525228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-resolved contrast-enhanced three-dimensional pulmonary MR-angiography: 1.0 M gadobutrol vs. 0.5 M gadopentetate dimeglumine.
    Fink C; Bock M; Kiessling F; Lichy MP; Krissak R; Zuna I; Schmähl A; Delorme S; Kauczor HU
    J Magn Reson Imaging; 2004 Feb; 19(2):202-8. PubMed ID: 14745754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast material for abdominal dynamic contrast-enhanced 3D MR angiography with parallel imaging: intraindividual equimolar comparison of a macrocyclic 1.0 M gadolinium chelate and a linear ionic 0.5 M gadolinium chelate.
    Hadizadeh DR; Von Falkenhausen M; Kukuk GM; Schöneseiffen K; Gieseke J; Schild HH; Willinek WA
    AJR Am J Roentgenol; 2010 Mar; 194(3):821-9. PubMed ID: 20173166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced three-dimensional pulmonary perfusion magnetic resonance imaging: intraindividual comparison of 1.0 M gadobutrol and 0.5 M Gd-DTPA at three dose levels.
    Fink C; Puderbach M; Ley S; Plathow C; Bock M; Zuna I; Kauczor HU
    Invest Radiol; 2004 Mar; 39(3):143-8. PubMed ID: 15076006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional contrast-enhanced magnetic-resonance angiography of the renal arteries: interindividual comparison of 0.2 mmol/kg gadobutrol at 1.5 T and 0.1 mmol/kg gadobenate dimeglumine at 3.0 T.
    Attenberger UI; Michaely HJ; Wintersperger BJ; Sourbron SP; Lodemann KP; Reiser MF; Schoenberg SO
    Eur Radiol; 2008 Jun; 18(6):1260-8. PubMed ID: 18278504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance evaluation of renal artery stenosis in a swine model: performance of low-dose gadobutrol versus gadoterate meglumine in comparison with digital subtraction intra-arterial catheter angiography.
    Morelli JN; Runge VM; Ai F; Zhang W; Li X; Schmitt P; McNeal G; Miller M; Lennox M; Wusten O; Schoenberg SO; Attenberger UI
    Invest Radiol; 2012 Jun; 47(6):376-82. PubMed ID: 22543971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance evaluation of brain metastases from systemic malignances with two doses of gadobutrol 1.0 m compared with gadoteridol: a multicenter, phase ii/iii study in patients with known or suspected brain metastases.
    Katakami N; Inaba Y; Sugata S; Tsurusaki M; Itoh T; Machida T; Tanaka H; Nakayama T; Morikawa T; Breuer J; Aitoku Y
    Invest Radiol; 2011 Jul; 46(7):411-8. PubMed ID: 21467949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraindividual quantitative and qualitative comparison of gadopentetate dimeglumine and gadobutrol in time-resolved contrast-enhanced 4-dimensional magnetic resonance angiography in minipigs.
    Hadizadeh DR; Jost G; Pietsch H; Weibrecht M; Perkuhn M; Boschewitz JM; Keil VC; Träber F; Kukuk GM; Schild HH; Willinek WA
    Invest Radiol; 2014 Jul; 49(7):457-64. PubMed ID: 24598442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral magnetic resonance angiography with continuous table movement in combination with high spatial and temporal resolution time-resolved MRA With a total single dose (0.1 mmol/kg) of gadobutrol at 3.0 T.
    Voth M; Haneder S; Huck K; Gutfleisch A; Schönberg SO; Michaely HJ
    Invest Radiol; 2009 Sep; 44(9):627-33. PubMed ID: 19652610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do highly concentrated gadolinium chelates improve MR brain perfusion imaging? Intraindividually controlled randomized crossover concentration comparison study of 0.5 versus 1.0 mol/L gadobutrol.
    Tombach B; Benner T; Reimer P; Schuierer G; Fallenberg EM; Geens V; Wels T; Sorensen AG
    Radiology; 2003 Mar; 226(3):880-8. PubMed ID: 12601217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput gadobutrol-enhanced CMR: a time and dose optimization study.
    D'Angelo T; Grigoratos C; Mazziotti S; Bratis K; Pathan F; Blandino A; Elen E; Puntmann VO; Nagel E
    J Cardiovasc Magn Reson; 2017 Nov; 19(1):83. PubMed ID: 29110679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 0.5 M gadoterate and 1.0 M gadobutrol in peripheral MRA: a prospective, single-center, randomized, crossover, double-blind study.
    Haneder S; Attenberger UI; Schoenberg SO; Loewe C; Arnaiz J; Michaely HJ
    J Magn Reson Imaging; 2012 Nov; 36(5):1213-21. PubMed ID: 22848033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Power Versus Manual Injection in Bolus Shape and Image Quality on Contrast-Enhanced Magnetic Resonance Angiography: An Experimental Study in a Swine Model.
    Tsuboyama T; Jost G; Pietsch H; Tomiyama N
    Invest Radiol; 2017 Sep; 52(9):547-553. PubMed ID: 28448310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced magnetic resonance imaging evaluation of VX2 carcinoma in a rabbit model: comparison of 1.0-M gadobutrol and 0.5-M gadopentetate dimeglumine.
    Chang JM; Moon WK; Cha JH; Jung EJ; Cho N; Kim SJ
    Invest Radiol; 2010 Oct; 45(10):655-61. PubMed ID: 20808238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1.0-M gadobutrol versus 0.5-M gadoterate for peripheral magnetic resonance angiography: a prospective randomized controlled clinical trial.
    Szucs-Farkas Z; Froehlich JM; Ulrich M; Wuersten HU; Guignard D; Wyss S; Braunschweig M
    J Magn Reson Imaging; 2008 Jun; 27(6):1399-405. PubMed ID: 18504760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gadobutrol in the central nervous system at three doses: results from a phase II, randomized, multicenter trial.
    Breuer J; Gutierrez J; Latchaw R; Lehr R; Sorensen AG
    J Magn Reson Imaging; 2014 Feb; 39(2):410-8. PubMed ID: 23681501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-resolved MR angiography of renal artery stenosis in a swine model at 3 Tesla using gadobutrol with digital subtraction angiography correlation.
    Morelli JN; Ai F; Runge VM; Zhang W; Li X; Schmitt P; McNeal G; Michaely HJ; Schoenberg SO; Miller M; Gerdes CM; Sincleair ST; Spratt H; Attenberger UI
    J Magn Reson Imaging; 2012 Sep; 36(3):704-13. PubMed ID: 22645046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inter-individual Comparison of Gadobutrol and Gadoteridol Tissue Time-intensity Profiles for Dynamic Susceptibility Contrast Perfusion MR Imaging.
    Yamada M; Taoka T; Kawaguchi A; Yasuda K; Niinomi Y; Ohashi Y; Okuda T; Naganawa S
    Magn Reson Med Sci; 2019 Jan; 18(1):75-81. PubMed ID: 29794406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-to-Dose Relationship of Gadopiclenol, an MRI Macrocyclic Gadolinium-based Contrast Agent, Compared with Gadoterate, Gadobenate, and Gadobutrol in a Rat Brain Tumor Model.
    Robert P; Vives V; Grindel AL; Kremer S; Bierry G; Louin G; Ballet S; Corot C
    Radiology; 2020 Jan; 294(1):117-126. PubMed ID: 31660804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraindividual comparison of gadobenate dimeglumine and gadobutrol for cerebral magnetic resonance perfusion imaging at 1.5 T.
    Essig M; Lodemann KP; Le-Huu M; Brüning R; Kirchin M; Reith W
    Invest Radiol; 2006 Mar; 41(3):256-63. PubMed ID: 16481908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.